Ani Pharmaceuticals (ANIP) Receivables (2012 - 2026)
Ani Pharmaceuticals (ANIP) reported Receivables of $274.47 million for Q2 2026, up 21.6% from $225.65 million a year earlier and up 7.5% from the prior quarter.
Ani Pharmaceuticals (ANIP) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2025, Ani Pharmaceuticals posted Receivables of $281.08 million, up 26.8% from FY2024.
- Receivables has a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
- By year, Receivables came in at $221.73 million in FY2024 (+36.8%), $162.08 million in FY2023 (-2.0%), $165.44 million in FY2022 (+28.7%) and $128.53 million in FY2021 (+34.2%).
- Five-year quarterly Receivables spans a low of $106.71 million in Q3 2021 and a high of $281.08 million in Q4 2025.
- Year over year, Receivables has now increased in each of the last eight quarters, with growth averaging 25.4% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q2 2022 (growth of 62.3%); the low point was Q2 2024 (a decline of 4.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $255.43 million (Q1 2026), $281.08 million (Q4 2025) and $252.62 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Ani Pharmaceuticals | 1.43 Bn | 212.92 Mn | 165.89 Mn | 274.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 274.47 Mn |
| Mar 31, 2026 | 255.43 Mn |
| Dec 31, 2025 | 281.08 Mn |
| Sep 30, 2025 | 252.62 Mn |
| Jun 30, 2025 | 225.65 Mn |
| Mar 31, 2025 | 220.33 Mn |
| Dec 31, 2024 | 221.73 Mn |
| Sep 30, 2024 | 196.36 Mn |
| Jun 30, 2024 | 166.09 Mn |
| Mar 31, 2024 | 172.42 Mn |
| Dec 31, 2023 | 162.08 Mn |
| Sep 30, 2023 | 178.84 Mn |
| Jun 30, 2023 | 172.93 Mn |
| Mar 31, 2023 | 174.71 Mn |
| Dec 31, 2022 | 165.44 Mn |
| Sep 30, 2022 | 140.43 Mn |
| Jun 30, 2022 | 150.41 Mn |
| Mar 31, 2022 | 131.63 Mn |
| Dec 31, 2021 | 128.53 Mn |
| Sep 30, 2021 | 106.71 Mn |
Ani Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();